Thesis defense Julia Boshuizen

AXL as an anchor to combat cancer therapy resistance

Wednesday 30 December 2020 09:45 VU University Thesis defense

Julia Boshuizen
"Together with my colleagues, I discovered some special characteristics of the AXL protein. This protein can predict whether tumors will respond to the treatment. We now know that tumors often comprise a mix of cells with varying levels of AXL. This is why it is best to attack melanomas with a mixture of AXL inhibitors and regular treatment like immunotherapy. Even though I got off to a great start in academia with my research, I decided to take a break from the field. I now work at the OLVG hospital to see if I can – or want to – start working in internal medicine. I would love to combine scientific research with work in the clinic one day. I love seeing my patients, and they help me find research questions that matter the most to them.”

Thesis defense Julia Boshuizen

AXL as an anchor to combat cancer therapy resistance

This site uses cookies